Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Exp Neurol. 2020 Jun 8;331:113377. doi: 10.1016/j.expneurol.2020.113377

Figure 4.

Figure 4

A) The nitrergic component of the IJP is selectively reduced following T3-SCI in the presence of MRS-2179. B) Graph of evoked nitrergic IJPs in the presence of MRS-2179 shows a significant reduction in T3-SCI rats at both 3-days or 3-weeks as well as representative recordings of IJPs in the presence of MRS-2179. (Values expressed as mean ± SEM, *p < 0.05 vs. post-operative time-matched controls, n = 20).